These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3056279)

  • 1. [Phase II study of 5-FU tablet in bladder tumor].
    Ohmori H; Matsumura Y; Yoshimoto J; Obama T; Hara M; Josen Y; Ishido N; Nasu Y; Tanahashi T; Asahi T
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3115-20. PubMed ID: 3056279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phase II study of 5-FU tablet in bladder tumor].
    Nagamoto A; Kubota Y; Shuin T; Kondo I; Moriyama M; Satomi Y; Fukushima S; Fukuoka H; Ishizuka E; Furuhata A
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):845-50. PubMed ID: 2653223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase II study of 5-FU tablets in cancer of the uterine cervix].
    Sekiba K; Yajima A; Tenjin Y; Kurihara S; Akiya K; Okada K; Noda K; Ozaki M; Hasegawa K; Mori T
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2365-73. PubMed ID: 3606156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with breast cancer--multi-center cooperative study--Cooperative Study Group of 590-S in Breast Cancer].
    Taguchi T; Terasawa T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):467-71. PubMed ID: 3813575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Single drug chemotherapy with 5-FU oral administration of bladder cancer].
    Ueno M; Yoshikawa H; Hasegawa K; Sasaki H; Onodera Y; Ikeuchi T; Kai Y
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):2109-11. PubMed ID: 2221933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bropirimine (U-54461S) late phase II clinical study for carcinoma in situ of the bladder. Japan Bropirimine Study Group].
    Akaza H; Shimazaki J; Tashiro K; Kotake T; Okajima E; Kagawa S; Machida T
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):77-85. PubMed ID: 9020949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sequential methotrexate-5-fluorouracil (MTX-5-FU) treatment of patients with advanced gastric and colorectal cancer. Sequential Methotrexate-5-FU Study Group].
    Murakami M; Ota K; Miyazaki T; Niitsu Y; Wakui A; Yokoyama M; Kanamaru R; Futatsuki K; Akazawa S; Sakai Y
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2482-90. PubMed ID: 3619460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [5-Fluorouracil concentration in various tissues from cancer patients after oral administration of 5-fluorouracil].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J; Yoshimoto M; Nishidai H; Nakanishi Y; Kashi Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1037-48. PubMed ID: 6721512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on 5-FU concentration in serum and bladder tumor tissue after oral administration of UFT].
    Takayama H; Konami T; Konishi T; Pak K; Tomoyoshi T
    Hinyokika Kiyo; 1986 Oct; 32(10):1449-53. PubMed ID: 3105272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Group].
    Nakatsu T; Takahashi H; Furue H
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3114-8. PubMed ID: 3674897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The optimal period for orally administered fluoropyrimidines as an adjuvant chemotherapy for gastric cancer--a pilot study using 5-FU tablets compared with surgical operation alone].
    Fujii M; Sakabe T; Wakabayashi K; Kochi M; Mochizuki F; Kasakura Y; Yamagata M; Noro M; Osawa T; Iwai S
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1199-208. PubMed ID: 8031162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined hyperfractionated radiotherapy and protracted infusion chemotherapy in bladder cancer for organ preservation.
    Saracino B; Arcangeli G; Mecozzi A; Tirindelli Danesi D; Cruciani E; Altavista P; Giannarelli D
    Clin Ter; 1998; 149(3):183-9. PubMed ID: 9842100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).
    Aranda E; Cervantes A; Carrato A; Antón-Torres A; Massutí T; Fernández-Martos C; Díaz-Rubio E
    J Infus Chemother; 1996; 6(3):118-22. PubMed ID: 9229321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase II study of 5'-DFUR treatment of the bladder and prostatic cancer].
    Ohmori H; Matsumura Y; Ochi J; Kobashi K; Akebi N; Saika T; Nanba K; Tanahashi T; Josen T; Nasu Y
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2307-14. PubMed ID: 1834024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multi-institutional cooperative study on combination chemotherapy with THP, CDDP and 5-FU for squamous cell carcinoma of the head and neck].
    Urade M; Yanagisawa T; Kishimoto H; Yoshioka W; Teranobu O; Shigeta Y; Komori T; Shimada K; Ohnishi M; Tanaka Y; Kamiya Y; Akazawa N; Oko T; Takahashi N; Adachi R; Tanigaki S; Hirata Y; Yakushiji N; Kitamura R; Hashikawa N;
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):789-95. PubMed ID: 11432346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bropirimine (U-54461S) early phase II clinical studies--to investigate the efficacy and safety of bropirimine treatment on various malignant tumors (urological, hematologic, and dermal cancers)].
    Furue H; Machida T; Masaoka T; Ikeda S
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):67-75. PubMed ID: 9020948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
    Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ
    J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.